Elicio Therapeutics, Inc. ELTX
- ELI-002 7P — Pancreatic Ductal Adenocarcinoma Phase 2
- ELI-002 2P — Pancreatic Ductal Adenocarcinoma Phase 1
- ELI-002 7P — Colorectal Cancer Phase 1
KRAS (3 companies · 6 programs)
Companies with an active program directed at KRAS.
Erasca, Inc. ERAS
- ERAS-4001 Phase 1
- ERAS-4001 Phase 1
ARVINAS, INC. ARVN
- pan-KRAS degrader Preclinical